ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Society guideline links: Cocaine use and cocaine use disorder

Society guideline links: Cocaine use and cocaine use disorder

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

World Health Organization (WHO) and United Nations Office on Drugs and Crime (UNODC): International standards for the treatment of drug use disorders, revised edition incorporating results of field-testing (2020)

Canada

The Canadian Network for Mood and Anxiety Treatments (CANMAT): Recommendations for the management of patients with mood disorders and comorbid substance use disorders (2012)

United States

Substance Abuse and Mental Health Services Administration (SAMHSA): Treatment Improvement Protocol (TIP) for substance use disorder treatment and family therapy (2020)

US Preventive Services Task Force (USPSTF): Final recommendation statement on illicit drug use in children, adolescents, and young adults – Primary care-based interventions (2020)

USPSTF: Final recommendation statement on unhealthy drug use – Screening (2020)

SAMHSA: Evidence-based resource guide series – Substance misuse prevention for young adults (2019)

SAMHSA: Treatment Improvement Protocol (TIP) for enhancing motivation for change in substance use disorder treatment (2019)

American College of Physicians (ACP): Position paper on health and public policy to facilitate effective prevention and treatment of substance use disorders involving illicit and prescription drugs (2017)

American Academy of Pediatrics (AAP): Clinical report on families affected by parental substance use (2016)

AAP: Clinical report on substance use screening, brief intervention, and referral to treatment (2016)

SAMHSA: Treatment Improvement Protocol (TIP) for detoxification and substance abuse treatment (2015)

US Department of Veterans Affairs/Department of Defense (VA/DoD): Clinical practice guideline for the management of substance use disorders (2015)

SAMHSA: Treatment Improvement Protocol (TIP) for managing depressive symptoms in substance abuse clients during early recovery (2008, revised 2014)

SAMHSA: Treatment Improvement Protocol (TIP) for substance abuse treatment – Addressing the specific needs of women (2009, revised 2013)

SAMHSA: Quick guide for clinicians – Managing chronic pain in adults with or in recovery from substance use disorders (2013)

American Heart Association (AHA): Scientific statement for management of cocaine-associated chest pain and myocardial infarction (2008)

American Psychiatric Association (APA): Guideline watch − Practice guideline for the treatment of patients with substance use disorders, 2nd edition (2007)

APA: Practice guideline for the treatment of patients with substance use disorders, 2nd edition (2006)

United Kingdom

National Institute for Health and Care Excellence (NICE): Quality standard on drug misuse prevention (2018)

NICE: Guideline for drug misuse prevention − Targeted interventions (2017)

United Kingdom Department of Health (DH): Drug misuse and dependence – UK guidelines on clinical management (2017)

NICE: Guideline on coexisting severe mental illness and substance misuse – Community health and social care services (2016)

NICE: Guideline on controlled drugs − Safe use and management (2016)

British Association for Psychopharmacology (BAP): Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity, update (2012)

NICE: Quality standard on drug use disorders in adults (2012)

NICE: Coexisting severe mental illness (psychosis) with coexisting substance misuse – Assessment and management in adults and young people (2011)

Australia–New Zealand

Choosing Wisely Australia: Use a 'universal precautions' approach for all psychoactive medications that have known potential or liability for abuse including opioids, benzodiazepines, antipsychotic medications, gabapentinoids, cannabinoids and psychostimulants

South Australia Health (SA Health): Substance misuse and dependence (2021)

Choosing Wisely Australia: Avoid prescribing benzodiazepines to patients with a history of substance misuse (including alcohol) or multiple psychoactive drug use (2015)

Topic 134144 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟